Indokem growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025
−3.7%+10.1%
−23.9%+213.6%
−24.2%+211.2%
+131.5%+117.5%
+133.3%+117.5%
+3.0%+10.1%
+4.0%+1.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

INDOKEM₹611.00

Indokem Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASGRAUWEILJYOTIRESKANCHIMcap ₹1,690 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue Growth—+10.1-3.7
EBITDA Growth—+213.6-23.9
EBIT Growth—+211.2-24.2
Net Income Growth—+117.5+131.5
EPS Growth—+117.5+133.3
Total Assets Growth—+10.1+3.0
Total Equity Growth—+1.5+4.0
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.